A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called "study drugs". The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the combination of fianlimab and cemiplimab is in treating melanoma, in comparison with the combination of two medications, relatlimab and nivolumab, commercialized under the brand name Opdualag™ and approved for the treatment of melanoma in adults and children. The study is looking at several other research questions, including: * What side effects may happen from taking the study drugs. * How much study drug is in the blood at different times. * Whether the body makes antibodies against the study drugs (which could make the drug less effective or could lead to side effects)
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony czerniak skóry, który nie może być operacyjnie usunięty lub rozprzestrzenił się na inne części ciała
- •Brak wcześniejszego leczenia systemowego czerniaków zaawansowanych
- •Mierzalne zmiany nowotworowe widoczne w badaniach obrazowych
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu
- •Prawidłowe funkcjonowanie szpiku kostnego, wątroby i nerek
- •Znany status mutacji genu BRAF lub chęć wykonania takiego testu
✗ Disqualifies
- •Czerniak z innych części ciała niż skóra (np. oka, dłoni, błon śluzowych)
- •Choroby autoimmuniczne wymagające leczenia immunosupresyjnego w ciągu ostatnich 2 lat
- •Niekontrolowane zakażenia HIV, wirusem zapalenia wątroby B lub C
- •Wcześniejsze leczenie innymi lekami immunologicznymi (z pewnymi wyjątkami)
- •Bieżące przyjmowanie leków osłabiających układ odpornościowy
- •Historia zapalenia mięśnia sercowego
- •Wysokie markery uszkodzenia serca (troponina T lub I)
- •Przerzuty do mózgu lub uciśnięcie rdzenia kręgowego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (110)
Ironwood Cancer & Research Centers
Chandler, United States
Banner MD Anderson Cancer Center
Gilbert, United States
Arizona Oncology Associates
Tucson, United States
University of Arkansas for Medical Sciences
Little Rock, United States
Providence Medical Foundation
Fullerton, United States
Cancer and Blood Specialty Clinic
Los Alamitos, United States
University of California Los Angeles
Los Angeles, United States
St. Joseph Hospital Orange
Orange, United States
University of California Irvine, UCI Medical Center
Orange, United States
Eisenhower Medical Center
Rancho Mirage, United States
Emad Ibrahim, MD, Inc.
Redlands, United States
Sutter Health
Sacramento, United States
University of California San Francisco (UCSF)
San Francisco, United States
Sansum Clinic
Santa Barbara, United States
St John's Cancer Institute
Santa Monica, United States
Rocky Mountain Regional VA Medical Center
Aurora, United States
University of Colorado Cancer Center
Aurora, United States
The Melanoma And Skin Cancer Institute
Englewood, United States
UCHealth
Fort Collins, United States
Yale Cancer Center
New Haven, United States
Clermont Oncology Center
Clermont, United States
Mayo Clinic Florida
Jacksonville, United States
Cancer Specialist of North Florida
Jacksonville, United States
Boca Raton Clinical Research (BRCR) Global
Tamarac, United States
H. Lee Moffitt Cancer Center
Tampa, United States
University Cancer & Blood Center
Athens, United States
John B. Amos Cancer Center
Columbus, United States
Beacon Clinic
Coeur d'Alene, United States
Hope and Healing Cancer Services
Hinsdale, United States
Advocate Lutheran General Hospital
Park Ridge, United States
Illinois CancerCare
Peoria, United States
Fort Wayne Medical Oncology and Hematology
Fort Wayne, United States
The University of Kansas Cancer Center
Westwood, United States
Markey Cancer Center Clinical Research Organization
Lexington, United States
Mary Bird Perkins Cancer Center
Baton Rouge, United States
Maryland Oncology Hematology, P.A.
Columbia, United States
University of Michigan
Ann Arbor, United States
Karmanos Cancer Institute
Detroit, United States
Henry Ford Cancer Institute/Henry Ford Health System
Detroit, United States
Minnesota Oncology Hematology, P.A
Fridley, United States
Allina Health Cancer Institute
Minneapolis, United States
VA St. Louis Healthcare System
St Louis, United States
Washington University School of Medicine
St Louis, United States
Mercy South
St Louis, United States
St. Vincent Healthcare
Billings, United States
Oncology Hematology West P.C. dba Nebraska Cancer Specialists
Omaha, United States
Comprehensive Cancer Centers of Nevada
Las Vegas, United States
Dartmouth Hitchcock Medical Center
Lebanon, United States
John Theurer Cancer Center
Hackensack, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, United States
The Valley Hospital Inc.
Paramus, United States
New York Oncology Hematology
Albany, United States
Messino Cancer Center
Asheville, United States
Levine Cancer Institute
Charlotte, United States
Novant Health Cancer Institute
Charlotte, United States
Novant Health Weisiger Cancer Institute - Charlotte
Charlotte, United States
Duke Health System
Durham, United States
Novant Health Zimmer Cancer Institute - Wilmington
Wilmington, United States
Oncology Hematology Care Clinical Trials
Cincinnati, United States
Seidman Cancer Center
Cleveland, United States
The Ohio State University Wexner Medical Center
Columbus, United States
Oklahoma Cancer Specialists and Research Institute, LLC
Tulsa, United States
USOR Willamette Valley Cancer Institute and Research Center
Eugene, United States
Kaiser Foundation Hospitals
Portland, United States
Oregon Health and Science University
Portland, United States
St. Luke's University Health Network
Easton, United States
Fox Chase Cancer Center
Philadelphia, United States
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center
Pittsburgh, United States
Lifespan Cancer Institute
Providence, United States
Saint Francis Cancer Center
Greenville, United States
Tennessee Oncology - Chattanooga
Chattanooga, United States
University of Tennessee Medical Center
Knoxville, United States
Sarah Cannon Research Institute (SCRI) Oncology Partners
Nashville, United States
Tennessee Oncology
Nashville, United States
Texas Oncology - Austin Midtown, Midtown Medical Center I
Austin, United States
Texas Oncology - Austin Central, Central Austin Cancer Center
Austin, United States
Texas Oncology - Bedford
Bedford, United States
Texas Oncology - Medical City
Dallas, United States
Texas Oncology
Dallas, United States
Center For Disease And Blood Disorder
Fort Worth, United States
Texas Oncology - Fort Worth
Fort Worth, United States
Texas Oncology - Grapevine
Grapevine, United States
Texas Oncology - Harlingen, Medical Arts Pavillion
Harlingen, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
Texas Oncology - Longview
Longview, United States
Joe Arrington Cancer Research & Treatment Center
Lubbock, United States
Texas Oncology - McAllen
McAllen, United States
Texas Oncology-Palestine Cancer Center
Palestine, United States
The University of Texas Health Science Center at Tyler D/B/A UT Health East Texas HOPE Cancer Center
Tyler, United States
Texas Oncology-Tyler, Northeast Texas Cancer Institute
Tyler, United States
Texas Oncology - Weslaco, Knapp Medical Plaza
Weslaco, United States
University of Utah Huntsman Cancer Institute
Salt Lake City, United States
University of Virginia
Charlottesville, United States
Inova Schar Cancer Institute
Fairfax, United States
Virginia Cancer Specialists, PC
Fairfax, United States
Virginia Oncology Associates
Norfolk, United States
Virginia Commonwealth University Massey Cancer Center
Richmond, United States
Oncology & Hematology Associates of Southwest Virginia, Inc.
Roanoke, United States
Swedish Cancer Institute - Edmonds Campus
Edmonds, United States
Swedish Cancer Institute - Issaquah Campus
Issaquah, United States
Kadlec Clinic Hematology and Oncology
Kennewick, United States
Swedish Cancer Institute
Seattle, United States
West Virginia University
Morgantown, United States
University of Wisconsin Carbone Cancer Center
Madison, United States
Cross Cancer Institute
Edmonton, Canada
London Regional Cancer Centre
London, Canada
Sunnybrook Health Sciences Centre
Toronto, Canada
Princess Margaret Cancer Centre
Toronto, Canada
Jewish General Hospital - Main Address
Montreal, Canada
Centre Hospitalier Universitaire de Quebec (CHUQ) - Centre Hospitalier de l'Universite Laval (CHUL)
Québec, Canada
Trial contact
Clinical Trials Administrator
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.